Pityriasis rubra pilaris (PRP) is an idiopathic inflammatory hyperproliferative chronic dermatosis characterized by: perifollicular coalescing papules with central keratotic acuminate plugs gradually submerged in sheets of erythema; perifollicular erythema with islands of unaffected skin; palmoplantar keratoderma; diffuse desquamation which typically spreads from the head down to the feet. The cause of the condition is unknown, but possible etiological factors include: vitamin A deficiency, trauma, infections, autoimmune mechanisms, and malignancies. Taking into account different age of onset, clinical course, morphology and prognosis, there are six different types of the disease: two in adults (classical and atypical); three in children (classical, circumscribed and atypical); one in individuals infected with human immunodeficiency virus. This paper presents two male patients with clinical symptoms of classical PRP, 53 and 69 years of age at the onset of the disease, with rapid generalized involvement, typical erythematous perifollicular papules, islands of unaffected skin, palmoplantar hyperkeratosis with a waxy appearance and nail changes. The diagnosis was based on clinical findings and histopathologic analysis. Apart from topical therapy with emollients, corticosteroids and keratolytics, they received systemic retinoids and corticosteroids, which resulted in improvement of skin lesions. It is extremely important to consider the possible triggering factors, establish the diagnosis as soon as possible and begin proper treatment.
described in 1835 by Claudius Tarral, but he did not consider it to be a separate entity, but a variant of psoriasis (5) . In 1856, Alphonse Devergie described "pityriasis pilaris" as a combination of follicular lesions and psoriasis palmaris, pityriasis capillitii and pityriasis rubra, naming Tarral's case as pityriasis pilaris (6) , while in 1877 Richaud recognized it as a distinct entity (7). In 1889, Ernest Besnier named this condition -pityriasis rubra pilaris (8) , whereas in 1910, De Beurmann fi rst described the familial form of PRP (9) .
Th e incidence of PRP is low: in the United States it has been reported to occur with 1: 3500 to 1 : occurrence; b) begins at early childhood, after the fi rst year of life; c) previous infectious episode; d) scarlatiniform erythema followed by the appearance of follicular papules; e) no laboratory abnormalities, except for those derived from the infectious process; f ) clinical appearance similar to classic juvenile PRP, and g) acute course with good outcomes, although resolution may be slow, and no tendency toward recurrence.
In 1994, Piamphongsant and Akaraphant (16) analyzed 168 patients with PRP and proposed a new classifi cation that distinguished the following 4 types of PRP based on clinical appearance: 1. salmoncolored or erythematous thick plaques on the palms and soles, which extend beyond the dorsopalmar and plantar junctions; 2. circumscribed scaly erythematous patches on the elbows and knees; 3. patches involving large areas of the trunk which are not generalized; 4. exfoliative erythroderma associated with diff use follicular plugging. However, in practice, Griffi ths classifi cation is still actual, although in 1995 (17) sixth type was added: PRP associated with human immunodefi ciency virus (HIV) infection, which diff ers from other types in terms of clinical course and poor prognosis (18) . 5000 patients presenting in dermatology clinics (10) , in India, 1 case in every 500 new pediatric patients with a dermatologic disease (11) . It occurs equally in male and female patients; in childhood, the male to female ratio is 3:2 (3). It aff ects members of all races, but it is less common in black people. Although PRP may occur at any age (10) , it most commonly aff ects those in their fi rst, second, fi fth or sixth decades of life (1) . Usually these are sporadic acquired forms, familial forms are rare, being rather transplacentally transmitted (1) , than inherited in an autosomal dominant or autosomal recessive or X-linked fashion (3, 12) .
Based on the age of onset, clinical course, morphology and prognosis, in 1980 Griffi ths (13) classifi ed PRP into fi ve types: two adult types (classical and atypical) and three juvenile types (classic, circumscribed and atypical). In 1983, Larregue et al. (14) described a new variant, as a subtype of type III, acute or postinfection juvenile PRP (15) . Th e characteristics of this type include: a) no familial Figure 1 . Th e skin of the abdomen: a) intense individual and coalescing erythematous plaques covered with thin whitish poorly adherent scales with well demarcated islands of unaff ected skin; b) an enhanced detail parakeratosis, mild acanthosis with short and broad rete ridges; a nonspecifi c perivascular infi ltrate in the papillary and subpapillary dermis composed predominantly of lymphocytes ( Figure 3 ).
Th erapy
Th e patient received a systemic corticosteroid therapy for 15 days and after initial improvement, acitretin was initiated at a dose of 75 mg per day, which was gradually reduced to 25 mg per day; topical treatment included corticosteroids, emollients and keratolytics. On discharge, the patient showed a signifi cant improvement of skin lesions.
Patient 2. A 70-year-old retired male patient, diagnosed with erythroderma, was admitted due to skin changes that began 6 months earlier on his right cheek with redness, itching and subsequent scaling. Th e skin lesions then spread to the chest, abdomen, shoulders and back, with intense itching. Almost from the beginning, the disease also aff ected the palms, soles and nails, with painful thickening. A month before admission, the patient developed burning in the eyes and his eyelids were stuck together in the morning. He received outpatient treatment without
Case reports
Patient 1. A 53-year-old farmer, with a diagnosis of erythroderma, was admitted due to skin changes that appeared 15 days earlier including redness and itching of the scalp, which soon spread to the whole body. His personal and family medical histories were unremarkable. Th e dermatological examination revealed: intense erythematous plaques on the whole body, especially on arms and legs, covered with thin whitish poorly adherent scales with well demarcated islands of unaff ected skin ( Figure 1) ; the skin of the face and scalp was erythematous with fi ne velvety desquamation; the hands and feet were edematous with palmoplantar hyperkeratosis and a waxy appearance, shallow rhagades and a marked lamellar desquamation mostly on the palms (Figure 2) .
Laboratory test results
All relevant laboratory fi ndings were within normal limits, except for slightly elevated cholesterol and triglyceride levels.
Histopathological analysis Histopathological examination of the fully developed erythematous lesion showed a moderate to prominent orthokeratosis with alternating Figure 2 . Palmar hyperkeratosis with a waxy appearance with shallow rhagades and a marked lamellar desquamation signifi cant improvement, and when the changes spread to the whole body, half a year after the onset of symptoms, he was referred to hospital for examination and treatment. Apart from elevated blood pressure, the patient's personal and family history were unremarkable; dermatological examination showed: pinhead-sized erythematous follicular papules on the chest and abdomen, single or coalescing, forming plaques with whitish pityriasiform scaling ( Figure 4) ; red-orange lesions with diff use thickening were found on the face, neck, back, arms and legs, covered with whitish scales with islets of healthy skin ( Figure 5) ; the skin of both palms and soles was thickened, yellowishbrown with a wax appearance ( Figure 6 ); the distal third parts of the nail plates of the fi ngers and toes were yellowish and thickened, with longitudinal ridging and subungual hyperkeratosis.
All relevant laboratory fi ndings were within normal limits. After examination, the ophthalmologist diagnosed blepharoconjunctivitis, and 3% solution of boric acid eye drops was introduced, as well as chloramphenicol eye ointment. (19) , vaccination against diphtheriatetanus-polio, fl u vaccination, and vaccination against measles, mumps and rubella (25, 26) . Cases associated with HIV infection have also been reported
Histopathological analysis
Histopathological examination of the areas corresponding to follicular papules showed: dilated infundibulum fi lled with orthokeratotic plug; the hairs were present, but reduced in volume ( Figure  7) ; perifollicular parakeratosis; mild perifollicular lymphocytic infi ltrate.
Th erapy
Th e treatment was initiated with parenteral methylprednisolone (the initial dosage of 80 mg per day, with gradual reduction of the daily dose), and systemic antihistamines; topical treatment included corticosteroids, emollients and keratolytics. Th e patient was discharged in a much improved condition: reduced erythema, desquamation and infi ltration of the skin, especially on the palms and soles.
Discussion and a Literature Review
PRP is rare heterogeneous dermatosis with unclear etiology and pathogenesis (19, 20) . Th e skin lesions are the result of hyperproliferation of keratinocytes in the epidermis and infl ammation in the dermis. In conjunction with the genetic background, Figure 5 . Th e skin of both palms and soles is thickened, yellowish-brown with a waxy appearance orange-red or salmon-colored with scaly plaques, with sharp borders, with islands of unaff ected skin not exceeding 1.5 cm in diameter. Th e nails show a yellow-brown discoloration, subungual hyperkeratosis, nail-plate thickening, and splinter hemorrhages. Lesions of the mucous membranes include white plaques confi ned to the palate, bilateral gray-white plaques with a rough surface in the buccal mucosa and erythematous lesions, even erosions (30) . Complications may involve the eyes: ectropion, blurred vision and dry eyes.
Griffi th's classifi cation (13) , which is generally used, gives precise descriptions of the PRP types.
Type I is classic adult pityriasis rubra pilaris which accounts for 50 to 55% of all cases (4) . Th e onset is acute, it is sporadic and there are no familial cases. PRP is characterized by cephalocaudal progression. Scarring alopecia may also develop (31) . It has the best prognosis: about 80% of patients have remission in an average of 3 years. One reported case resolved spontaneously after 20 years (32) .
Type II is atypical, accounting for 5% of patients. It is characterized by: marked desquamation, thin hair, increased palmoplantar keratosis, ichthyosiform lamellar scales, alopecia, incomplete erythroderma, (17, 27) . It seems that infections and other triggers act only as initiators of the aberrant cell-mediated immune response. Th e absence of prodromic symptoms in both our patients, as in most cases, cannot eliminate the possibility of an asymptomatic illness triggering PRP.
Besides acquired, sporadic cases, familial cases of PRP have been reported, most commonly with autosomal dominant inheritance (10) . Mutations in the CARD14 gene on chromosome 17q25 (28) , which encodes a group of interactive protein known as nuclear factor-kappa B (NF-kB), have been found in some families. NF-kB regulates the activity of multiple genes, including genes that control immune responses and infl ammatory reactions; CARD14 gene mutations enhance the activation of NF-kB signaling pathway which causes an aberrant infl ammatory response. Th e CARD14 protein is found in many of the body's tissues, but it is particularly abundant in the skin, where it appears to play important roles in regulating infl ammatory reactions. Data obtained recently (28) , demonstrate that autosomal-dominant PRP is allelic to familial psoriasis, which was recently shown to be caused also by mutations in CARD14 gene (29) .
In PRP, skin, nails, mucous membranes, and eyes can be aff ected (10) . Th e skin is typically with clinical symptoms of classical PRP at the age of 53 and 69, respectively. Although there are no specifi c laboratory markers for PRP, all relevant laboratory and other tests were performed to detect the potential trigger factors (10) . Th e test results of both patients were within reference values. Although histological features are not pathognomonic in PRP, they are useful to rule out other possible papulosquamous and erythrodermic disorders (10) . In classical adult type, histopathological changes are distinctive, and vary depending on the stage and localization of lesions from which the biopsy is taken (1). It is characterized by hyperkeratosis with alternating orthoand parakeratosis, focal and confl uent hypergranulosis, follicular plugging with perifollicular parakeratosis forming a shoulder eff ect, short and broad rete ridges, and sparse superfi cial dermal lymphocytic perivascular infi ltration (35) . Acantholysis has been reported as an additional histological fi nding, and together with hypergranulosis, follicular plugs, dilated, but not tortuous dermal capillaries and absence of epidermal pustules, it may help to distinguish pityriasis rubra pilaris from psoriasis (35) . Unlike psoriasis, the acanthotic epidermis in PRP is not thinned above the dermal papillae (1). Histopathological fi ndings in type IV, circumscribed PRP diff er from those in classical: lamellar hyperkeratosis with unchanged or increased granular layer; marked follicular hyperkeratosis; scarce acanthosis; rare cell infi ltration (1) . Th e classical type I PRP was histologically confi rmed in both of our patients. In early stages, many diseases, including PRP, may have similar symptoms, so the diff erential diagnosis includes a series of dermatoses. In adults they are: contact dermatitis, scabies crustosa, cutaneous T-cell lymphoma, Darier's disease, dermatomyositis, eczema, erythroderma, lichen spinulosus, phrynoderma, psoriasis, pityriasis versicolor, pityriasis lichenoides chronica, pityriasis rosea, pityriasis rosealike drug eruption, psoriasis, subacute cutaneous lupus erythematosus, sclerodermiform dermatitis, dermatitis seborrhoica, secondary syphilis. In children, diff erential diagnosis includes: eczema, erythroderma variabilis, Kawasaki disease, lichen spinulosus, nummular dermatitis, phrynoderma (36) . Sometimes it is diffi cult to diff erentiate these lesions from psoriasis (37). Unlike psoriasis, PRP sometimes with psoriasiform appearance, but never progresses to psoriasis, and has no cephalocaudal spread. It has a long-term chronic course (11) , and lasts several years (10) .
Type III is a classic juvenile type, and accounts for 10% of all patients with PRP (3); it has the same clinical picture as Type I, but its onset is within the fi rst 2 years of life and the course is more favorable in children compared with adults. Classical juvenile type may progress into circumscribed form. Initially, it may resemble other superantigen-mediated diseases: staphylococcal scalded skin syndrome (SSSS), scarlet fever, toxic shock syndrome, and Kawasaki disease. It is featured by raspberry tongue, shiny, chapped lips, fl exural (particularly perineal) erythema followed by peeling, palmo-plantar erythema, and generalized rash, whereas usual lesions appear days or weeks later. Symptoms spontaneously resolve within 3 years or earlier (10) . In 6% of patients self-limitation occurs in the fi rst year, and in 90% in three years.
Type IV is circumscribed juvenile PRP and it occurs in prepubertal children or young adults. Th is form accounts for about 25% of all cases. It is characterized by sharply demarcated areas of follicular hyperkeratosis and erythema of the knees and the elbows. Sometimes it is extremely diffi cult to distinguish it from psoriasis. Th e long-term outcome is unclear; it rarely progresses; it may resolve spontaneously, but may also be persistent and last for several years (33) .
Type V is atypical juvenile generalized chronic PRP. Most familial PRP cases belong to this type (10) . It accounts for 5% of patients with PRP, and it is characterized by diff use ichthyosiform follicular lesions on the feet, with severe keratoderma, and sclerodermiform palmoplantar lesions, mostly without erythema.
Type VI is associated with HIV infection (17). It is characterized by follicular keratosis, acneiform, nodular and pustular lesions with elongated follicular plugs or lichen spinulosus-type lesions on the face and upper trunk, often with clear symptoms of immune defi ciency (10) . It signifi cantly diff ers from other types of PRP, it is refractory to treatment and it has an increasing incidence (4) .
Th e diagnosis of PRP is based on clinical and histological fi ndings (10, 34) . Our patients presented ustekinumab, adalimumab (18, 20, 22, 42, (44) (45) (46) (47) . Phototherapy (UVB, NB UVB, PUVA) can be eff ective as monotherapy, or combined with retinoids (48). Treatment of refractory juvenile PRP with synthetic retinoid-analogue bexarotene, has shown good therapeutic eff ects (49). Tumor necrosis factor alpha (TNF-) inhibitors have been used with various success, but their long-term use may cause serious side eff ects (50, 51). Based on their experience and literature review, Muller et al., (46) found infl iximab monotherapy as fi rst-line treatment for adultonset PRP (type I).
Our fi rst patient was initially treated with systemic corticosteroids, but they were found ineff ective. A systemic retinoid was initiated, as well as topical therapy with corticosteroids, emollients and keratolytics, and this treatment resulted in signifi cant improvement. Th e second patient was treated with systemic corticosteroids with benefi cial therapeutic eff ects.
Conclusion
We presented two adult males with classical clinical picture of type I PRP. Th e diagnosis was based on clinical appearance and histological fi ndings, and both had a favorable response to treatment. It is of utmost importance to be familiar with potential triggers of the disease, make early diagnosis, and start proper treatment.
has the following features: bimodal age of onset; general state of the patient is good, even in those with erythroderma; the presence of islets of unaff ected skin is easy to distinguish from areas of uninvolved skin in psoriatic erythroderma if we bear in mind that "islands of unaff ected skin" in PRP do not exceed 1.5 cm in diameter; the primary lesion is papule with a hair in its center with no inclination to peripheral growth and fusion due to skin infi ltration, but due to an ongoing erythematosquamous process when diff use erythroderma is formed; brick-red or carrot-orange color; absence of infi ltrates, lichenifi cation, large lamellar scales; absence of onycholysis; palmoplantar hyperkeratosis without infi ltration, with yelloworange discoloration; rare seronegative arthropathy; variable response to methotrexate; hormonal therapy, primarily with corticosteroids, has no favorable eff ects; pure response to UVB therapy (1, 38) .
Regarding complications of PRP, we should rather consider them as various associations of uncertain signifi cance (1). PRP has been reported to be associated with: photosensitivity, increased susceptibility to herpes simplex eye infection, ectropion and vision disorders (39) . Our older patient presented with eye irritation and watering; an ophthalmologist was consulted, but the patient did not develop ectropion. PRP is also associated with poor quality of life, depression, insomnia, suicidal ideation (40) . Particular attention should be paid to the side eff ects of drugs used in the treatment of PRP, primarily retinoids (41) .
Th e therapy is very diverse, with diff erent results; treatment of children with PRP should be done with special caution and in most cases include topical agents only. Topical therapy involves the use of diff erent agents such as emollients and keratolytics, creams with urea and lactic acid, corticosteroids, vitamin D analogues (calcipotriol), retinoids, imiquimod 5% (20, 22, 42, 43, 44) . In systemic therapy results are unpredictable, although retinoids are widely considered the fi rst-line treatment in the erythrodermic phase; methotrexate has been eff ective as an alternative or adjunct to oral retinoids but generally is less effi cacious in PRP than in psoriasis; success and failure have been reported with cyclosporine, as well as with corticosteroids, high doses of vitamin A, vitamin E, antihistamines, azathioprine, biological agents such as infl iximab, folikularne hiperkeratotične papule grupisane u široke eritematozne plaže, između kojih se nalaze ostrvca neizmenjene kože, palmoplantarna keratodermija, difuzne skvame u kosmatom delu glave i, često, progresivna eksfolijativna eritrodermija. Bolest se retko registruje u Americi − jedan oboleli na 3 500−5 000 novoregistrovanih slučajeva dermatoloških oboljenja među pacijentima koji se javljaju na pregled dermatologu. Kod odraslih bolest se javlja podjenako često kod oba pola, dok je kod dece češća kod dečaka (odnos dečaka prema devojčicama je 3 : 2). Obolevaju pripadnici svih rasa, nešto ređe crne rase. Iako se PRP može javiti u bilo kom periodu života, najčešće započinje u prvoj, drugoj, petoj ili šestoj dekadi. Najčešće su to sporadični stečeni slučajevi, dok je pojava PRP među pripadnicima iste porodice posledica najverovatnije transplacentarnog prenošenja, ređe autozomno dominantnog, autozomno recesivnog, ili nasleđivanja vezanog za X hromozom. Zbog razlika u vremenu početka bolesti, kliničkom toku, morfologiji i prognozi, Grifi ts (Griffi ths) je 1980. godine izvršio klasifi kaciju PRP na pet tipova: dva tipa kod odraslih (klasični i atipični) i tri juvenilna tipa (klasični, cirkumskriptni i atipični). Larege (Larregue) i saradnici su 1983. godine opisali novu varijantu kao podtip tipa III, akutni ili postinfekcioni juvenilni PRP, što se retko navodi u literaturi. Karakteristike ovog tipa su: a) odsustvo porodičnog javljanja; b) početak u detinjstvu, posle prve godine života; c) prisustvo prethodne infekcije; d) skarlatiniformni eritem, sa kasnijom pojavom folikularnih papula; e) nema laboratorijskih abnormalnosti, sem onih u vezi sa infektivnim procesom; f ) klinički sličan klasičnom juvenilnom tipu; g) akutni tok sa dobrom prognozom, mada rezolucija može biti spora, ali bez tendencije ponovnog javljanja. Piamphongsant i Akaraphant su 1994. godine predložili novu klasifi kaciju oboljenja na osnovu analize 168 pacijenata sa PRP koja razlikuje sledeća četiri tipa PRP na osnovu kliničkog izgleda promena: 1. eritematozni zadebljali plakovi na dlanovima i tabanima sa širenjem na dorzopalmarne i plantarne zglobove; 2. eritemoskvamozni plakovi na kolenima i laktovima; 3. eritemoskvamozni plakovi koji zahvataju široke areale na trupu, bez generalizacije; 4. eksfolijativna eritrodermija udružena sa difuznim folikularnim čepovima. U praksi je međutim i dalje aktuelna podela Grifi tsa na pet tipova, kojima je 1995. godine dodat i šesti tip: PRP udružen sa infekcijom virusom humane imunodefi cijencije (HIV) koji se od ostalih tipova razlikuje po kliničkoj slici i lošijoj prognozi. Prikaz slučaja. Slučaj 1. Bolesnik mušog pola, starosti 53 godine, po zanimanju zemljoradnik, sa uputnom dijagnozom eritrodermije, primljen je na bolničko lečenje zbog promena na koži, koje su počele 15 dana ranije sa crvenilom i svrabom na kosmatom delu glave, a ubrzo su se proširile na čitavo telo. Lična i porodična anamneza bile su bez osobenosti; dermatološki pregled je otkrio: na koži čitavog tela, naročito ruku i nogu, pojedinačne i većim delom slivene intenzivno eritematozne plaže prekrivene tankim beličastim slabo adherentnim skvamama, sa ostrvcima neizmenjene kože između njih (Slika 1); na koži lica i kapilicijuma eritem sa sitnom brašnastom deskvamacijom; na šakama i stopalima edemi, palmoplantarna hiperkeratoza voštanog izgleda, sa plićim ragadama i krupnom lameloznom deskvamacijom, naročito izraženom na dlanovima (Slika 2). U laboratorijskim nalazima, osim lako povišenih nivoa holesterola i triglicerida u serumu, svi ostali relevanti laboratorijski nalazi bili su u granicama normale. Histopatološki pregled eritematozne lerzije: u epidermisu umerena do jače izražena ortokeratoza i alternativna parakeratoza, blaga akantoza sa plitkim i širokim grebenima; u papilama i subpapilarno perivaskularno prisutan oskudan nespecifi čan infi ltrat sastavljen pretežno od limfocita (Slika 3). Posle sistemske kortikosteroidne terapije u prvih 15 dana, koja je dala početno poboljšanje, u terapiju je uključen acitretin u dozi od 75 mg dnevno, sa postepenim smanjivanjem na 25 mg dnevno; u lokalnoj terapiji primenjeni su kortikosteroidi, emolijensi i keratolitici. Bolesnik je otpušten na kućno lečenje znatno poboljšanog stanja kože. Slučaj 2. Osoba muškog pola, stara 70 godina, po zanimanju penzioner, sa uputnom dijagnozom eritrodermije, primljen je na bolničko lečenje zbog promena na koži koje su počele 6 meseci ranije i to na koži desnog obraza u vidu crvenila i svraba, sa kasnijim perutanjem. Promene su zatim zahvatile kožu na grudima, trbuhu, ramenima i leđima, uz jak osećaj svraba. Skoro od samog početka bolesti nastale su promene na dlanovima, tabanima i noktima u vidu zadebljanja i bolne osetljivosti. Mesec dana pred prijem u bolnicu, javio se osećaj pečenja u očima i "slepljenost" očnih kapaka u jutarnjim časovima nakon buđenja. Lečen je ambulantno bez znatnijeg uspeha, a kada su se promene proširile na čitavo telo, pola godine od početka bolesti, upućen je na hospitalno ispitivanje i lečenje. Osim podatka o povišenom krvnom pritisku, lična i porodična anamneza bile su bez relevantnih osobenosti; dermatološki pregled je otkrio: na koži prednje strane grudnog koša i trbuha folikularne eritematoznene papule veličine čiodine glave, pojedinačne i slivene, sa beličastim pitijaziformnim skvamama (Slika 4); na koži lica, vrata, leđa, ruku i nogu difuzno zadebljanje neravne površine crvenonarandžaste boje, prekriveno beličastim skvamama, sa ostrvcima zdrave kože (Slika 5); na koži oba dlana i tabana difuzno zadebljanje, žućkastosmeđe prebojeno − voštanog izgleda (Slika 6); u distalnim trećinama nokatnih ploča na prstima ruku i nogu žućkasobeličasto prebojena zadebljanja, sa uzdužnim grebenima i subungvalnom hiperkeratozom. Svi relevanti laboratorijski nalazi bili su u granicama normale. Histopatološki pregled folikularne papule: folikul dlake dilatiran, ispunjen ortokeratinskim čepom; dlaka je prisutna, ali redukovanog volumena (Slika 7); perifolikularna parakeratoza; oskudni limfocitni perifolikularni infi ltrat. Lečenje je započeto sa parenteralnom primenom metilprednizona, u početnoj dozi od 80 mg dnevno, uz postepeno smanjivanje dnevne doze, i sistemskom primenom antihistaminika; u lokalnoj terapiji primenjeni su kortikosteroidi, emolijensi i keratolitici; pregledom oftalmologa postavljena je dijagnoza blefarokonjunktivitisa, a lečenje je sprovedeno rastvorom borne kiseline 3%, u vidu kapi za oči i aplikacijom hloramfenikol masti za oči. Bolesnik je otpušten na kućno lečenje u znatno poboljšanom stanju: redukovan eritem, deskvamacija i infi ltracija naročito kože na dlanovima i tabanima. Diskusija. Pityriasis rubra pilaris je retka u osnovi heterogena dermatoza sa nejasnom etiopatogenezom. Promene na koži su rezultat hiperproliferacije keratinocita u epidermisu i infl amacije u dermisu. Pored genetske predispozicije, različiti infektivni, endogeni i egzogeni ekološki faktori, npr. Promenama na koži, na noktima, mukoznim membranama i očima može da se manifestuje PRP. Na koži su tipični narandžastocrveni ili crvenkasto prebojeni skvamozni plakovi sa oštrim ivicama, između kojih se nalaze ostrvca neizmenjene kože koja po večini ne prelaze 1,5 cm u dijametru. Na noktima se može registrovati distalna žućkasto-smeđa diskoloracija, subungvalna hiperkeratoza, longitudinalne brazde, zadebljale nokatne ploče i hemoragije. Promene na mukoznim membranama su u vidu beličastih plakova, sivobelih papula ili plakova, eritema ili čak erozija na sluzokoži usta. Kao komplikacije na očima mogu nastati ektropion, nejasan vid i suvoća očiju. Prema klasifi kaciji Grifi tsa koja je u opticaju i opšte korišćena, dati su preciznije opisi naznačenih tipova. Tip I je klasični tip koji se javlja kod odraslih i prisutan je kod 50% do 55% svih obolelih. Tip II je atipičan, javlja se u oko 5% pacijenata, praćen je izraženom deskvamacijom nekada psorijaziformnog izgleda, ali nikada ne prelazi u psorijazu. Tip III je klasični juvenilni tip; javlja se kod 10% od svih pacijenata sa PRP, ima istu kliničku sliku kao tip I, ali se javlja u prve dve godine života i ima povoljniji tok nego kod odraslih. U početku, klinički podseća na superantigenom izazvana oboljenja: šarlah, toksični šok sindrom i Morbus Kawasaki. Uobičejene karakteristike su malinast jezik, sjajne ispucale usne, fl eksuralni (posebno perinealni) eritem koji prati ljuštenje, palmoplantarni eritem i generalizovani osip, dok se promene klasične PRP javljaju danima ili nedeljama kasnije. Tip IV je cirkumskriptni juvenilni tip koji se javlja kod prepubertetske dece i mlađih odraslih osoba. Nastaje kod 25% od svih bolesnika sa PRP. Karakterišu ga oštro ograničene skvamozne plaže folikularne hiperkeratoze i eritema na kolenima i laktovima. Tip V je atipična juvenilna generalizovana hronična forma. Najveći broj slučajeva PRP sa familijarnim javljanjem pripada ovom tipu. Nastaje kod 5% obolelih od PRP. Karakterišu ga difuzne folikularne lezije ihtioziformnog izgleda na nogama, sa značajnom keratodermijom, sklerodermiformnim promenama na palmarnim i plantarnim regijama i neretko eritem. Tip VI je udružen sa infekcijom HIV-om: promene su na licu i gornjem delu trupa u vidu folikularne keratoze, akneiformnih lezija nodularnih i pustuloznih, sa elongiranim folikularnim čepovima, lezijama sličnim lihen spinulozusu i često naglašenim znacima imunodefi cijencije. Signifi kantno se razlikuje od drugih tipova, refrakteran je na terapiju a incidencija mu je u porastu (4). Dijagnoza PRP se postavlja na osnovu kliničkog efekat postignt već nakon početne primene sistemskih kortikosteroida. Zaključak. Prikazali smo dve odrasle muške osobe sa klasičnom kliničkom slikom PRP tip I, kod kojih je dijagnoza potavljena na osnovu kliničkog izgleda i patohistološkog nalaza i koje su povoljno reagovale na primenjenu terapiju. Izuzetno je važno poznavati mogućnost dejstva raznih mogućih okidača bolesti, na vreme postaviti dijagnozu i započeti adekvatno lečenje.
